ABOUT

X-ZELL was founded on a simple conviction: minimally invasive cancer diagnostics should be faster, more informative and accessible at scale. As an award-winning medical technology company and proud Y Combinator alumnus, we are dedicated to empowering cytopathology — one of the most impactful yet underutilized tools in modern cancer diagnostics. Cytology enables disease detection from single cells or small cell clusters obtained through minimally invasive fluids or fine-needle aspirations (FNA). Despite its clinical value, it has long been limited by resource-intensive workflows and restricted data yield. At X-ZELL, we are building a next-generation cytology paradigm that unites multiplex laboratory processing with digital imaging in a seamless, same-day workflow. Our mission is to help laboratories, hospitals, and researchers extract richer diagnostic insights from less invasive samples—advancing digitally integrated data and a more patient-centered diagnostic experience. Thank you for your interest in X-ZELL.

Dr. Sebastian C.P. Bhakdi, Founder & CSO